Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 4 of the last 4 fiscal years.
-
Two loss years in a row NBB
Negative result in 2023 and 2024.
-
Busy address KBO
37 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2024
VASCULAR RESEARCH NETWORK BVBA from Leuven, company number BE0564780124, closed financial year 2024 with a result of € -9,572 after tax. Compared with financial year 2023, the result moved from € -9,018 to € -9,572. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2025.
€ -158,577
▼ € 9,572 vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -9,572
▼ 6 % more loss than in 2023
Profit after tax over the fiscal year.
€ 40,199
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -177,177.
People and assets in 2024
0
Average over the fiscal year, from the social balance sheet.
Debts at end 2024
None
No bank loans on the last day of the fiscal year.
€ 2,632
Supplier invoices still open on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2021 | 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|---|
| Gross margin | € 8,373 | € 3 | € 0 | - | |
| Profit after taxes | € 117 | € -9,048 | € -9,018 | € -9,572 | ▼ € 554 |
| Equity | € -130,939 | € -139,987 | € -149,005 | € -158,577 | ▼ € 9,572 |
| Total debts | € 176,625 | € 184,958 | € 194,074 | € 203,646 | ▲ 5% |
| Cash | € 41,301 | € 40,101 | € 40,199 | € 40,199 | |
| Retained profit | € -149,539 | € -158,587 | € -167,605 | € -177,177 | ▼ € 9,572 |
| Balance sheet total | € 45,686 | € 44,970 | € 45,069 | € 45,069 |
Key figures of VASCULAR RESEARCH NETWORK BVBA, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to VASCULAR RESEARCH NETWORK BVBA?
What happened at VASCULAR RESEARCH NETWORK BVBA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2024: loss of € 9,572. Source: NBB ↗
- New establishment in Leuven. KBO
- Start of the company according to the CBE. KBO
In short
From € 117 profit in 2021 to € 9,572 loss in 2024.
Best year ever: 2021, with € 117 profit.
A new publication or filing at VASCULAR RESEARCH NETWORK BVBA? We notify you, reason included.
Follow VASCULAR RESEARCH NETWORK BVBADatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind VASCULAR RESEARCH NETWORK BVBA is Excelya NL ANDERE.
Directors
According to the 2024 annual accounts
Excelya NL ANDERE
Director · represented by Frederic Pacqueville
Establishments
Establishment units
Physical locations of this company
Grauwmeer 1 box 5
3001 Leuven
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 37 companies are registered at this address.
All companies at this address →BARKERSECO
€ -3,500 gross margin · 2024
NEMESIS
€ 20,051 gross margin · 2024
VABEL
€ -1,500 gross margin · 2024
FELVES
€ -14,285 gross margin · 2023
Hoydonckx en Partners - Bedrijfsrevisoren - Hoydonckx et Partners - Reviseurs d'Entreprises
€ -10,711 gross margin · 2025
+32 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0564.780.124
- VAT number
- BE 0564.780.124
- Registered office
- Grauwmeer 1 bus 5, 3001 Leuven
- Names & denominations
- VASCULAR RESEARCH NETWORK BVBA · VRN BVBA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 16 October 2014
- Peppol
- Active · Active since 27 Mar 2026